| Enhanced radiation sensitivity in HPV-positive head and neck cancer RJ Kimple, MA Smith, GC Blitzer, AD Torres, JA Martin, RZ Yang, CR Peet, ... Cancer research 73 (15), 4791-4800, 2013 | 433 | 2013 |
| iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration R Singh, W Shen, D Kuai, JM Martin, X Guo, MA Smith, ET Perez, ... Human molecular genetics, dds469, 2012 | 242 | 2012 |
| U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies MA Smith, GS Choudhary, A Pellagatti, K Choi, LC Bolanos, TD Bhagat, ... Nature cell biology, 1, 2019 | 185 | 2019 |
| Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck GC Blitzer, MA Smith, SL Harris, RJ Kimple International Journal of Radiation Oncology* Biology* Physics 88 (4), 761-770, 2014 | 141 | 2014 |
| Functional analysis of serially expanded human iPS cell-derived RPE cultures R Singh, MJ Phillips, D Kuai, J Meyer, JM Martin, MA Smith, ET Perez, ... Investigative ophthalmology & visual science 54 (10), 6767, 2013 | 137 | 2013 |
| Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs T Muto, CS Walker, K Choi, K Hueneman, MA Smith, Z Gul, ... Nature Immunology 21 (5), 535-545, 2020 | 114 | 2020 |
| Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts RJ Kimple, PM Harari, AD Torres, RZ Yang, BJ Soriano, M Yu, ... Clinical Cancer Research 19 (4), 855-864, 2013 | 103 | 2013 |
| Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR YL Wang, AM Overstreet, MS Chen, J Wang, HJ Zhao, PC Ho, M Smith, ... Oncotarget 6 (13), 11150, 2015 | 85 | 2015 |
| Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration R Singh, D Kuai, KE Guziewicz, J Meyer, M Wilson, J Lu, M Smith, E Clark, ... Molecular Therapy, 2015 | 66 | 2015 |
| Deconstructing innate immune signaling in myelodysplastic syndromes ME Varney, K Melgar, M Niederkorn, MA Smith, L Barreyro, ... Experimental hematology 43 (8), 587-598, 2015 | 36 | 2015 |
| Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies AP Stein, AD Swick, MA Smith, GC Blitzer, RZ Yang, S Saha, PM Harari, ... Cancer medicine 4 (5), 699-712, 2015 | 30 | 2015 |
| Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations G Choudhary, A Pellagatti, B Agianian, M Smith, TD Bhagat, ... bioRxiv, 2022 | 28 | 2022 |
| Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia L Barreyro, AM Sampson, C Ishikawa, KM Hueneman, K Choi, MA Pujato, ... Science Translational Medicine 14 (635), eabb7695, 2022 | 13 | 2022 |
| SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML GS Choudhary, MA Smith, A Pellagatti, TD Bhagat, S Gordon, S Pandey, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 13 | 2019 |
| TNFAIP3 plays a role in aging of the hematopoietic system MA Smith, AE Culver-Cochran, ER Adelman, GW Rhyasen, A Ma, ... Frontiers in immunology 11, 2020 | 12 | 2020 |
| Inhibition of UBE2N As a Therapeutic Approach in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) L Barreyro, AM Sampson, L Bolanos, M Niederkorn, M Pujato, MA Smith, ... Blood 128 (22), 579-579, 2016 | 4 | 2016 |
| Alternative Splice Variants of IRAK4 That Activate Innate Immune Signaling Are Associated with U2AF1 Mutations in Myelodysplastic Syndrome and Acute Myeloid Leukemia MA Smith, K Choi, N Salomonis, MJ Walter, K Komurov, DT Starczynowski Blood 128 (22), 1531-1531, 2016 | 2 | 2016 |
| Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies L Barreyro, A Sampson, K Hueneman, LC Bolanos, M Pujato, ... Blood 132 (Suppl 1), 4050-4050, 2018 | 1 | 2018 |
| Treatment of diseases associated with activated irak M Smith, D Starczynowski, K Komurov US Patent App. 16/339,692, 2021 | | 2021 |
| Alternative Splicing and Regulation of Innate Immune Mediators in Normal and Malignant Hematopoiesis M Smith University of Cincinnati, 2019 | | 2019 |
